Biogen saw the highest growth of 149% in patent filings and 199% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 63% and grants by 66%. GlobalData’s DataBook provides a comprehensive analysis of Biogen‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Biogen has been focused on protecting inventions in European Patent Office(EPO) with 16 publications in Q1 2024

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 25% filings and 3% grants. The European Patent Office(EPO), United States(US), South Korea(KR), and Australia(AU) patent Office are among the top ten patent offices where Biogen is filings its patents. Among the top granted patent authorities, Biogen has 19% of its grants in United States(US), 19% in Israel(IL) and 3% in European Patent Office(EPO).

F. Hoffmann-La Roche could be the strongest competitor for Biogen

In terms of grant share, Biogen stands in fifth position among its competitors. F. Hoffmann-La Roche and Biogen secured the top positions according to recent patent publication data.

Patents related to rare diseases and climate change lead Biogen's portfolio

Biogen has the highest number of patents in rare diseases followed by, climate change and healthtech. For rare diseases, nearly 50% of patents were filed and 39% of patents were granted in Q1 2024.

Alzheimer's disease related patents lead Biogen portfolio followed by epilepsy, and multiple sclerosis

Biogen has highest number of patents in alzheimer's disease followed by epilepsy, multiple sclerosis, dementia, and tauopathies. For alzheimer's disease, nearly 4% of patents were filed and 4% of patents were granted in Q1 2024.

For comprehensive analysis of Biogen's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.